Evaluation of the cost-utility of orlistat (Xenical) in the United Kingdom

被引:1
|
作者
McEwan, P
Jones, M
Farina, C
Currie, CJ
机构
[1] Univ Wales Coll Cardiff, Cardiff, S Glam, Wales
[2] Roche Prod Ltd, Welwyn Garden City, Herts, England
[3] Cardiff Res Consortium, Cardiff, S Glam, Wales
关键词
D O I
10.1016/S1098-3015(10)65900-1
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:721 / 721
页数:1
相关论文
共 50 条
  • [41] Cost-utility analysis for UTIs
    Schaefer, SE
    JOURNAL OF FAMILY PRACTICE, 1997, 44 (04): : 329 - 329
  • [42] Cost-Effectiveness of PHMB & betaine wound bed preparation compared with standard care in venous leg ulcers: A cost-utility analysis in the United Kingdom
    Cooper, Dawn M.
    Bojke, Chris
    Ghosh, Pinaki
    JOURNAL OF TISSUE VIABILITY, 2023, 32 (02) : 262 - 269
  • [43] Cost-utility analysis in schizophrenia
    Awad, AG
    Voruganti, LP
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 : 22 - 28
  • [44] The cost-utility of abatacept in Sweden
    Borgstrom, Fredrik
    Ametorp, Sofie
    Sennfalt, Karin
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 26 - 26
  • [45] COST-UTILITY OF GALLSTONE LITHOTRIPSY
    BASS, EB
    STEINBERG, EP
    CLINICAL RESEARCH, 1989, 37 (02): : A308 - A308
  • [46] Cost-utility analysis - Response
    Neumann, PJ
    Chapman, RH
    Stone, PW
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) : 626 - 626
  • [47] Cost-utility analysis and otolaryngology
    Hamilton, D.
    Hulme, C.
    Flood, L.
    Powell, S.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2014, 128 (02): : 112 - 118
  • [48] The Utility of Cost-Utility Analyses in Critical Care
    Kahn, Jeremy M.
    CRITICAL CARE MEDICINE, 2021, 49 (04) : 702 - 704
  • [49] Orlistat for the treatment of obesity: Cost utility model
    Foxcroft, D
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S153 - S153
  • [50] Orlistat for the treatment of obesity: cost utility model
    Foxcroft, DR
    OBESITY REVIEWS, 2005, 6 (04) : 323 - 328